Anti-coronavirus vaccine named PastoCovac as a joint venture between Iran and Cuba is being produced at Pasteur Institute of Iran (IPI). PastoCovac jointly manufactured by IPI and Cuba's Finlay Institute of Vaccines can help boost the span and scope of public vaccination in Iran. The third phase of the clinical trial of Iranian-Cuban COVID-19 vaccine started in April, Tehran, Iran, December 21, 2021. IRNA/Meysam Alaqehmandan
1483**1424
Follow us on Twitter @IrnaEnglish
Your Comment